Obesity Trial, Recruiting NCT06609200 Sponsor: Nanyang Technological University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06609200
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women between 21 and 65 years old
  • People with a Body Mass Index (BMI) of 25 or higher (a standard measure of body weight relative to height)
  • People whose blood test results show a HOMA-IR score of 2.14 or higher — this is a measure of how well the body responds to insulin, calculated from fasting blood sugar and insulin levels (confirm with trial site)
  • People who have not been following any weight loss program or taken any medications related to weight management in the past 3 months

Who may not be able to join:

  • People who have diabetes
  • People currently taking medications that may affect how the body uses insulin
  • People whose body weight has changed by 10% or more in the past 6 months
  • People who have a hormonal or gland-related condition, such as a thyroid disorder, pituitary gland disorder, or sex hormone disorder
  • People who have a heart condition, such as an irregular heartbeat, heart failure, or a history of heart attack, or who have a pacemaker
  • People who have an allergy or immune system disorder
  • People who have a tendency to bleed easily or have a bleeding disorder
  • Women who are pregnant or breastfeeding
  • People with reduced liver or kidney function
  • People who have had a stroke, or who are unable to exercise

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Linda Zhong, Ph.D., nanyang technological university traditional chinese medicine clinic

Phone: +65 8864 9477

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanyang Technological University
Registry
ClinicalTrials.gov
Start date
10 October 2024
Est. completion
9 April 2026

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

delta HOMA-IR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov